25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

InnoTherapy Inc
Buy, Hold or Sell?

Let's analyze Innotherapy together

I guess you are interested in InnoTherapy Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of InnoTherapy Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about InnoTherapy Inc

I send you an email if I find something interesting about InnoTherapy Inc.

1. Quick Overview

1.1. Quick analysis of Innotherapy (30 sec.)










1.2. What can you expect buying and holding a share of Innotherapy? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩2,595.34
Expected worth in 1 year
₩5,812.40
How sure are you?
55.6%

+ What do you gain per year?

Total Gains per Share
₩3,217.07
Return On Investment
31.8%

For what price can you sell your share?

Current Price per Share
₩10,120.00
Expected price per share
₩9,780 - ₩11,850
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Innotherapy (5 min.)




Live pricePrice per Share (EOD)
₩10,120.00
Intrinsic Value Per Share
₩-10,650.47 - ₩-9,187.48
Total Value Per Share
₩-8,055.13 - ₩-6,592.15

2.2. Growth of Innotherapy (5 min.)




Is Innotherapy growing?

Current yearPrevious yearGrowGrow %
How rich?$13.2m$9.1m$4.1m31.0%

How much money is Innotherapy making?

Current yearPrevious yearGrowGrow %
Making money-$3.5m-$4.1m$661.9k18.8%
Net Profit Margin-380.2%-1,615.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Innotherapy (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Innotherapy?

Welcome investor! Innotherapy's management wants to use your money to grow the business. In return you get a share of Innotherapy.

First you should know what it really means to hold a share of Innotherapy. And how you can make/lose money.

Speculation

The Price per Share of Innotherapy is ₩10,120. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Innotherapy.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Innotherapy, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩2,595.34. Based on the TTM, the Book Value Change Per Share is ₩804.27 per quarter. Based on the YOY, the Book Value Change Per Share is ₩407.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Innotherapy.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.480.0%-0.480.0%-0.570.0%-0.440.0%-0.370.0%
Usd Book Value Change Per Share0.560.0%0.560.0%0.290.0%0.180.0%0.200.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.560.0%0.560.0%0.290.0%0.180.0%0.200.0%
Usd Price Per Share6.21-6.21-5.99-8.38-4.66-
Price to Earnings Ratio-12.85--12.85--10.44--21.11--11.73-
Price-to-Total Gains Ratio11.03-11.03-21.02--7.40--7.40-
Price to Book Ratio3.42-3.42-4.78-6.58-3.66-
Price-to-Total Gains Ratio11.03-11.03-21.02--7.40--7.40-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.084
Number of shares141
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.560.18
Usd Total Gains Per Share0.560.18
Gains per Quarter (141 shares)79.3825.44
Gains per Year (141 shares)317.52101.74
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10318308010292
206356260203194
309539440305296
40127012620407398
50158815800509500
60190518980610602
70222322160712704
80254025340814806
90285828520916908
10031753170010171010

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.09.00.00.0%0.09.00.00.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%5.04.00.055.6%5.04.00.055.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%5.04.00.055.6%5.04.00.055.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of InnoTherapy Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--804.267804.2670%407.264+97%257.703+212%288.371+179%
Book Value Per Share--2595.3362595.3360%1791.069+45%1923.596+35%1258.744+106%
Current Ratio--3.1433.1430%2.218+42%8.101-61%9.048-65%
Debt To Asset Ratio--0.3730.3730%0.577-35%0.403-7%0.481-22%
Debt To Equity Ratio--0.5950.5950%1.362-56%0.921-35%0.588+1%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--53348724610.00053348724610.0000%49397750280.000+8%81875061198.000-35%81875061198.000-35%
Eps---690.101-690.1010%-819.927+19%-633.324-8%-522.512-24%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--40.35140.3510%133.588-70%137.060-71%137.060-71%
Free Cash Flow Per Share---785.092-785.0920%-685.780-13%-830.106+6%-618.023-21%
Free Cash Flow To Equity Per Share---785.092-785.0920%-704.949-10%1.760-44719%97.388-906%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---9187.484--------
Intrinsic Value_10Y_min---10650.470--------
Intrinsic Value_1Y_max---851.539--------
Intrinsic Value_1Y_min---999.334--------
Intrinsic Value_3Y_max---2611.201--------
Intrinsic Value_3Y_min---3079.207--------
Intrinsic Value_5Y_max---4434.384--------
Intrinsic Value_5Y_min---5227.106--------
Market Cap73708008000.000+12%64603758000.00064603758000.0000%62345904000.000+4%87225998400.000-26%48458888000.000+33%
Net Profit Margin---3.802-3.8020%-16.150+325%-8.147+114%-46.895+1134%
Operating Margin----0%-0%-2.3660%-16.5310%
Operating Ratio--4.8814.8810%14.269-66%7.568-36%20.199-76%
Pb Ratio3.899+12%3.4183.4180%4.779-28%6.584-48%3.658-7%
Pe Ratio-14.665-14%-12.853-12.8530%-10.440-19%-21.114+64%-11.730-9%
Price Per Share10120.000+12%8870.0008870.0000%8560.000+4%11976.000-26%6653.333+33%
Price To Free Cash Flow Ratio-12.890-14%-11.298-11.2980%-12.482+10%-16.069+42%-8.927-21%
Price To Total Gains Ratio12.583+12%11.02911.0290%21.018-48%-7.400+167%-7.400+167%
Quick Ratio--1.4151.4150%3.211-56%12.428-89%12.085-88%
Return On Assets---0.167-0.1670%-0.194+16%-0.185+11%-0.286+72%
Return On Equity---0.266-0.2660%-0.458+72%-0.345+30%-0.344+29%
Total Gains Per Share--804.267804.2670%407.264+97%257.703+212%288.371+179%
Usd Book Value--13232007.92213232007.9220%9131548.846+45%9807221.096+35%6417554.250+106%
Usd Book Value Change Per Share--0.5630.5630%0.285+97%0.180+212%0.202+179%
Usd Book Value Per Share--1.8171.8170%1.254+45%1.347+35%0.881+106%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--37344107.22737344107.2270%34578425.196+8%57312542.839-35%57312542.839-35%
Usd Eps---0.483-0.4830%-0.574+19%-0.443-8%-0.366-24%
Usd Free Cash Flow---4002698.469-4002698.4690%-3496368.757-13%-4232193.462+6%-3150916.134-21%
Usd Free Cash Flow Per Share---0.550-0.5500%-0.480-13%-0.581+6%-0.433-21%
Usd Free Cash Flow To Equity Per Share---0.550-0.5500%-0.493-10%0.001-44719%0.068-906%
Usd Market Cap51595605.600+12%45222630.60045222630.6000%43642132.800+4%61058198.880-26%33921221.600+33%
Usd Price Per Share7.084+12%6.2096.2090%5.992+4%8.383-26%4.657+33%
Usd Profit---3518397.246-3518397.2460%-4180300.831+19%-3228937.118-8%-2663973.958-24%
Usd Revenue--925472.723925472.7230%258843.536+258%488336.489+90%335783.486+176%
Usd Total Gains Per Share--0.5630.5630%0.285+97%0.180+212%0.202+179%
 EOD+6 -2MRQTTM+0 -0YOY+25 -105Y+20 -1510Y+20 -15

3.3 Fundamental Score

Let's check the fundamental score of InnoTherapy Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-14.665
Price to Book Ratio (EOD)Between0-13.899
Net Profit Margin (MRQ)Greater than0-3.802
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.415
Current Ratio (MRQ)Greater than13.143
Debt to Asset Ratio (MRQ)Less than10.373
Debt to Equity Ratio (MRQ)Less than10.595
Return on Equity (MRQ)Greater than0.15-0.266
Return on Assets (MRQ)Greater than0.05-0.167
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of InnoTherapy Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.027
Ma 20Greater thanMa 509,567.000
Ma 50Greater thanMa 1008,852.400
Ma 100Greater thanMa 2008,786.900
OpenGreater thanClose10,130.000
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About InnoTherapy Inc

SCL Science Inc., engages in the development and sale of medical sealant products in South Korea. The company's products include InnoSEAL, an externally applied hemostatic agent; InnoSEAL Plus, an absorbable hemostatic pad; EndoSil, an absorbable hemostatic agent used for the gastrointestinal oozing bleeding; GellySil, a biomaterial and the proprietary material product. It also provides Film-type surgical sealant to complete sealing of anastomosis site; STOP needle, a self-sealing needle for general and ophthalmic use; wound dressing used for chronic wounds, burns, etc.; and Gene therapy, a bio-therapeutics delivery system. The company was formerly known as InnoTherapy, Inc. and changed its name to SCL Science Inc. in March 2024. SCL Science Inc. was founded in 2010 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2025-01-21 17:11:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Innotherapy earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Innotherapy to the Medical Devices industry mean.
  • A Net Profit Margin of -380.2% means that ₩-3.80 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of InnoTherapy Inc:

  • The MRQ is -380.2%. The company is making a huge loss. -2
  • The TTM is -380.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-380.2%TTM-380.2%0.0%
TTM-380.2%YOY-1,615.0%+1,234.8%
TTM-380.2%5Y-814.7%+434.5%
5Y-814.7%10Y-4,689.5%+3,874.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-380.2%-6.4%-373.8%
TTM-380.2%-13.8%-366.4%
YOY-1,615.0%-14.5%-1,600.5%
5Y-814.7%-14.5%-800.2%
10Y-4,689.5%-14.2%-4,675.3%
4.3.1.2. Return on Assets

Shows how efficient Innotherapy is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Innotherapy to the Medical Devices industry mean.
  • -16.7% Return on Assets means that Innotherapy generated ₩-0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of InnoTherapy Inc:

  • The MRQ is -16.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -16.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.7%TTM-16.7%0.0%
TTM-16.7%YOY-19.4%+2.7%
TTM-16.7%5Y-18.5%+1.8%
5Y-18.5%10Y-28.6%+10.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.7%-2.3%-14.4%
TTM-16.7%-3.0%-13.7%
YOY-19.4%-3.9%-15.5%
5Y-18.5%-2.7%-15.8%
10Y-28.6%-3.4%-25.2%
4.3.1.3. Return on Equity

Shows how efficient Innotherapy is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Innotherapy to the Medical Devices industry mean.
  • -26.6% Return on Equity means Innotherapy generated ₩-0.27 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of InnoTherapy Inc:

  • The MRQ is -26.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -26.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-26.6%TTM-26.6%0.0%
TTM-26.6%YOY-45.8%+19.2%
TTM-26.6%5Y-34.5%+7.9%
5Y-34.5%10Y-34.4%-0.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.6%-2.8%-23.8%
TTM-26.6%-3.9%-22.7%
YOY-45.8%-4.0%-41.8%
5Y-34.5%-4.0%-30.5%
10Y-34.4%-4.9%-29.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of InnoTherapy Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Innotherapy is operating .

  • Measures how much profit Innotherapy makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Innotherapy to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of InnoTherapy Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-236.6%+236.6%
5Y-236.6%10Y-1,653.1%+1,416.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.2%+13.2%
TTM--21.6%+21.6%
YOY--12.2%+12.2%
5Y-236.6%-16.0%-220.6%
10Y-1,653.1%-15.1%-1,638.0%
4.3.2.2. Operating Ratio

Measures how efficient Innotherapy is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 4.88 means that the operating costs are ₩4.88 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of InnoTherapy Inc:

  • The MRQ is 4.881. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.881. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.881TTM4.8810.000
TTM4.881YOY14.269-9.388
TTM4.8815Y7.568-2.687
5Y7.56810Y20.199-12.632
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8811.270+3.611
TTM4.8811.298+3.583
YOY14.2691.323+12.946
5Y7.5681.358+6.210
10Y20.1991.303+18.896
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of InnoTherapy Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Innotherapy is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.14 means the company has ₩3.14 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of InnoTherapy Inc:

  • The MRQ is 3.143. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.143. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.143TTM3.1430.000
TTM3.143YOY2.218+0.925
TTM3.1435Y8.101-4.958
5Y8.10110Y9.048-0.948
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1432.595+0.548
TTM3.1432.722+0.421
YOY2.2182.926-0.708
5Y8.1013.506+4.595
10Y9.0483.508+5.540
4.4.3.2. Quick Ratio

Measures if Innotherapy is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Innotherapy to the Medical Devices industry mean.
  • A Quick Ratio of 1.41 means the company can pay off ₩1.41 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of InnoTherapy Inc:

  • The MRQ is 1.415. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.415. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.415TTM1.4150.000
TTM1.415YOY3.211-1.797
TTM1.4155Y12.428-11.013
5Y12.42810Y12.085+0.342
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4151.465-0.050
TTM1.4151.586-0.171
YOY3.2111.889+1.322
5Y12.4282.360+10.068
10Y12.0852.548+9.537
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of InnoTherapy Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Innotherapy assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Innotherapy to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.37 means that Innotherapy assets are financed with 37.3% credit (debt) and the remaining percentage (100% - 37.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of InnoTherapy Inc:

  • The MRQ is 0.373. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.373. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.373TTM0.3730.000
TTM0.373YOY0.577-0.203
TTM0.3735Y0.403-0.029
5Y0.40310Y0.481-0.078
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3730.401-0.028
TTM0.3730.404-0.031
YOY0.5770.368+0.209
5Y0.4030.428-0.025
10Y0.4810.449+0.032
4.5.4.2. Debt to Equity Ratio

Measures if Innotherapy is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Innotherapy to the Medical Devices industry mean.
  • A Debt to Equity ratio of 59.5% means that company has ₩0.60 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of InnoTherapy Inc:

  • The MRQ is 0.595. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.595. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.595TTM0.5950.000
TTM0.595YOY1.362-0.767
TTM0.5955Y0.921-0.325
5Y0.92110Y0.588+0.333
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5950.572+0.023
TTM0.5950.619-0.024
YOY1.3620.547+0.815
5Y0.9210.643+0.278
10Y0.5880.715-0.127
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Innotherapy generates.

  • Above 15 is considered overpriced but always compare Innotherapy to the Medical Devices industry mean.
  • A PE ratio of -12.85 means the investor is paying ₩-12.85 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of InnoTherapy Inc:

  • The EOD is -14.665. Based on the earnings, the company is expensive. -2
  • The MRQ is -12.853. Based on the earnings, the company is expensive. -2
  • The TTM is -12.853. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.665MRQ-12.853-1.811
MRQ-12.853TTM-12.8530.000
TTM-12.853YOY-10.440-2.413
TTM-12.8535Y-21.114+8.260
5Y-21.11410Y-11.730-9.384
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-14.665-1.483-13.182
MRQ-12.853-1.747-11.106
TTM-12.853-2.144-10.709
YOY-10.440-2.985-7.455
5Y-21.114-2.447-18.667
10Y-11.730-2.141-9.589
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of InnoTherapy Inc:

  • The EOD is -12.890. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -11.298. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -11.298. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.890MRQ-11.298-1.592
MRQ-11.298TTM-11.2980.000
TTM-11.298YOY-12.482+1.184
TTM-11.2985Y-16.069+4.771
5Y-16.06910Y-8.927-7.142
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-12.890-1.568-11.322
MRQ-11.298-1.976-9.322
TTM-11.298-2.193-9.105
YOY-12.482-5.144-7.338
5Y-16.069-3.717-12.352
10Y-8.927-4.469-4.458
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Innotherapy is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 3.42 means the investor is paying ₩3.42 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of InnoTherapy Inc:

  • The EOD is 3.899. Based on the equity, the company is fair priced.
  • The MRQ is 3.418. Based on the equity, the company is fair priced.
  • The TTM is 3.418. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.899MRQ3.418+0.482
MRQ3.418TTM3.4180.000
TTM3.418YOY4.779-1.362
TTM3.4185Y6.584-3.166
5Y6.58410Y3.658+2.926
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD3.8992.148+1.751
MRQ3.4182.239+1.179
TTM3.4182.409+1.009
YOY4.7792.966+1.813
5Y6.5844.254+2.330
10Y3.6584.647-0.989
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Minority Interest  19,90661,37981,284-70,54410,741-10,64199-823-724



6.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets30,157,902
Total Liabilities11,255,033
Total Stockholder Equity18,902,868
 As reported
Total Liabilities 11,255,033
Total Stockholder Equity+ 18,902,868
Total Assets = 30,157,902

Assets

Total Assets30,157,902
Total Current Assets10,546,160
Long-term Assets19,611,742
Total Current Assets
Cash And Cash Equivalents 5,045,145
Short-term Investments 4,104,643
Net Receivables 643,100
Inventory 264,873
Total Current Assets  (as reported)10,546,160
Total Current Assets  (calculated)10,057,761
+/- 488,399
Long-term Assets
Property Plant Equipment 15,774,354
Intangible Assets 1,166,166
Long-term Assets  (as reported)19,611,742
Long-term Assets  (calculated)16,940,520
+/- 2,671,222

Liabilities & Shareholders' Equity

Total Current Liabilities3,355,592
Long-term Liabilities7,899,441
Total Stockholder Equity18,902,868
Total Current Liabilities
Short Long Term Debt 1,471,149
Accounts payable 675
Other Current Liabilities 0
Total Current Liabilities  (as reported)3,355,592
Total Current Liabilities  (calculated)1,471,824
+/- 1,883,768
Long-term Liabilities
Long term Debt 5,830,830
Capital Lease Obligations Min Short Term Debt351,903
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)7,899,441
Long-term Liabilities  (calculated)6,182,733
+/- 1,716,708
Total Stockholder Equity
Total Stockholder Equity (as reported)18,902,868
Total Stockholder Equity (calculated)0
+/- 18,902,868
Other
Capital Stock3,618,415
Common Stock Shares Outstanding 7,237
Net Debt 2,256,834
Net Invested Capital 26,204,847
Net Working Capital 7,190,567
Property Plant and Equipment Gross 15,893,904



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
8,110,204
7,032,168
4,203,917
11,176,488
17,232,558
17,351,021
31,882,777
30,814,409
30,157,902
30,157,90230,814,40931,882,77717,351,02117,232,55811,176,4884,203,9177,032,1688,110,204
   > Total Current Assets 
4,808,887
2,974,026
888,573
8,075,873
11,422,828
5,519,389
10,857,861
5,469,258
10,546,160
10,546,1605,469,25810,857,8615,519,38911,422,8288,075,873888,5732,974,0264,808,887
       Cash And Cash Equivalents 
2,380,663
1,073,504
222,052
341,586
5,852,393
575,632
1,030,682
927,119
5,045,145
5,045,145927,1191,030,682575,6325,852,393341,586222,0521,073,5042,380,663
       Short-term Investments 
2,128,337
1,003,308
0
3,000,000
4,900,000
4,062,402
9,390,107
3,000,000
4,104,643
4,104,6433,000,0009,390,1074,062,4024,900,0003,000,00001,003,3082,128,337
       Net Receivables 
142,474
321,423
68,941
232,023
204,421
128,165
81,230
96,464
643,100
643,10096,46481,230128,165204,421232,02368,941321,423142,474
       Other Current Assets 
8,168
6,708
2,215
184,558
205,381
148,336
7,425
86,982
0
086,9827,425148,336205,381184,5582,2156,7088,168
   > Long-term Assets 
0
0
0
0
0
11,831,632
21,024,917
25,345,151
19,611,742
19,611,74225,345,15121,024,91711,831,63200000
       Property Plant Equipment 
2,608,208
3,343,040
3,091,436
2,848,497
3,101,230
4,680,337
10,459,905
13,881,602
15,774,354
15,774,35413,881,60210,459,9054,680,3373,101,2302,848,4973,091,4363,343,0402,608,208
       Long Term Investments 
0
0
95,345
85,398
0
0
0
0
0
0000085,39895,34500
       Intangible Assets 
93,444
705,814
118,775
130,302
177,785
152,184
213,928
713,900
1,166,166
1,166,166713,900213,928152,184177,785130,302118,775705,81493,444
> Total Liabilities 
14,339,281
957,904
1,107,361
1,658,400
2,150,298
4,408,445
21,803,973
17,769,339
11,255,033
11,255,03317,769,33921,803,9734,408,4452,150,2981,658,4001,107,361957,90414,339,281
   > Total Current Liabilities 
3,086,896
539,768
140,396
293,294
950,037
835,853
657,415
2,465,456
3,355,592
3,355,5922,465,456657,415835,853950,037293,294140,396539,7683,086,896
       Short-term Debt 
490,957
0
0
0
0
0
0
0
0
00000000490,957
       Short Long Term Debt 
490,957
0
0
0
0
300,000
242,530
1,773,320
1,471,149
1,471,1491,773,320242,530300,0000000490,957
       Accounts payable 
0
0
0
0
2,112
4,659
2,631
18,454
675
67518,4542,6314,6592,1120000
       Other Current Liabilities 
2,595,939
539,768
140,396
234,565
309,335
336,123
0
0
0
000336,123309,335234,565140,396539,7682,595,939
   > Long-term Liabilities 
0
0
0
0
0
3,491,307
21,023,820
15,179,969
7,899,441
7,899,44115,179,96921,023,8203,491,30700000
       Long term Debt Total 
0
0
500,000
800,000
454,844
2,628,649
17,173,354
10,364,351
0
010,364,35117,173,3542,628,649454,844800,000500,00000
       Capital Lease Obligations Min Short Term Debt
-490,957
0
0
0
0
324,982
249,280
129,702
351,903
351,903129,702249,280324,9820000-490,957
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
000000000
       Deferred Long Term Liability 
580,042
571,880
0
0
0
0
0
0
0
0000000571,880580,042
> Total Stockholder Equity
-6,986,560
6,074,265
3,096,556
9,518,088
15,082,260
12,942,576
10,078,804
13,045,070
18,902,868
18,902,86813,045,07010,078,80412,942,57615,082,2609,518,0883,096,5566,074,265-6,986,560
   Common Stock
310,000
642,364
1,927,092
2,227,092
2,522,092
2,522,092
2,522,092
2,799,924
0
02,799,9242,522,0922,522,0922,522,0922,227,0921,927,092642,364310,000
   Retained Earnings -35,701,963-32,160,281-26,007,722-21,004,241-17,934,435-13,835,876-11,247,046-8,237,817-7,446,210
   Capital Surplus 
0
13,600,861
12,316,133
21,016,133
30,500,066
30,537,368
32,646,602
38,487,694
0
038,487,69432,646,60230,537,36830,500,06621,016,13312,316,13313,600,8610
   Treasury Stock000000000
   Other Stockholders Equity 
39,346
68,857
100,377
110,739
42,822
972,944
-7,176
-3,411
0
0-3,411-7,176972,94442,822110,739100,37768,85739,346



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,322,104
Cost of Revenue-1,113,690
Gross Profit208,414208,414
 
Operating Income (+$)
Gross Profit208,414
Operating Expense-5,339,286
Operating Income-4,017,182-5,130,871
 
Operating Expense (+$)
Research Development1,235,243
Selling General Administrative1,294,394
Selling And Marketing Expenses0
Operating Expense5,339,2862,529,637
 
Net Interest Income (+$)
Interest Income141,071
Interest Expense-730,771
Other Finance Cost-1
Net Interest Income-589,699
 
Pretax Income (+$)
Operating Income-4,017,182
Net Interest Income-589,699
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-5,023,480-4,017,182
EBIT - interestExpense = -730,771
-5,026,282
-4,295,511
Interest Expense730,771
Earnings Before Interest and Taxes (EBIT)0-4,292,709
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-5,023,480
Tax Provision-2,078
Net Income From Continuing Ops-5,025,558-5,025,558
Net Income-5,026,282
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0589,699
 

Technical Analysis of Innotherapy
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Innotherapy. The general trend of Innotherapy is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Innotherapy's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of InnoTherapy Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 11,850.

The bearish price targets are: 9,880 > 9,800 > 9,780.

Tweet this
InnoTherapy Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of InnoTherapy Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

InnoTherapy Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of InnoTherapy Inc. The current macd is 412.07.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Innotherapy price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Innotherapy. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Innotherapy price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
InnoTherapy Inc Daily Moving Average Convergence/Divergence (MACD) ChartInnoTherapy Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of InnoTherapy Inc. The current adx is 57.56.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Innotherapy shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
InnoTherapy Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of InnoTherapy Inc. The current sar is 9,303.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
InnoTherapy Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of InnoTherapy Inc. The current rsi is 67.03. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
InnoTherapy Inc Daily Relative Strength Index (RSI) ChartInnoTherapy Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of InnoTherapy Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Innotherapy price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
InnoTherapy Inc Daily Stochastic Oscillator ChartInnoTherapy Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of InnoTherapy Inc. The current cci is 71.86.

InnoTherapy Inc Daily Commodity Channel Index (CCI) ChartInnoTherapy Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of InnoTherapy Inc. The current cmo is 33.67.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
InnoTherapy Inc Daily Chande Momentum Oscillator (CMO) ChartInnoTherapy Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of InnoTherapy Inc. The current willr is -24.81203008.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Innotherapy is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
InnoTherapy Inc Daily Williams %R ChartInnoTherapy Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of InnoTherapy Inc.

InnoTherapy Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of InnoTherapy Inc. The current atr is 457.18.

InnoTherapy Inc Daily Average True Range (ATR) ChartInnoTherapy Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of InnoTherapy Inc. The current obv is 1,910,003.

InnoTherapy Inc Daily On-Balance Volume (OBV) ChartInnoTherapy Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of InnoTherapy Inc. The current mfi is 59.43.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
InnoTherapy Inc Daily Money Flow Index (MFI) ChartInnoTherapy Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for InnoTherapy Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-01-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

InnoTherapy Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of InnoTherapy Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.027
Ma 20Greater thanMa 509,567.000
Ma 50Greater thanMa 1008,852.400
Ma 100Greater thanMa 2008,786.900
OpenGreater thanClose10,130.000
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Innotherapy with someone you think should read this too:
  • Are you bullish or bearish on Innotherapy? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Innotherapy? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about InnoTherapy Inc

I send you an email if I find something interesting about InnoTherapy Inc.


Comments

How you think about this?

Leave a comment

Stay informed about InnoTherapy Inc.

Receive notifications about InnoTherapy Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.